-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Q-702 in Metastatic Hepatocellular Carcinoma (HCC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Q-702 in Metastatic Hepatocellular Carcinoma (HCC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Q-702 in Metastatic Hepatocellular Carcinoma (HCC) Drug Details:Q-702 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – RP-2 in Sarcomas
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - RP-2 in Sarcomas report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.RP-2 in Sarcomas Drug Details:RP-2 is under development for the treatment of mixed advanced...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pevonedistat Hydrochloride in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pevonedistat Hydrochloride in Solid Tumor report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Pevonedistat Hydrochloride in Solid Tumor Drug Details:Pevonedistat (MLN4924) is under development for...
-
Sector Analysis
Malta Beer and Cider Market Overview by Category, Price Dynamics, Brand and Flavour, Distribution and Packaging, 2023
Malta Beer and Cider Market Overview The Malta beer and cider market size was LCU93.6 million in 2022 and the market is expected to register a CAGR of more than 1% during 2023-2028. Malta Beer and Cider Market Outlook, 2022-2028 (LCU Million) Buy the Full Report for More Insights into the Malta Beer and Cider Market Forecast Download a Free Report Sample The Malta beer and cider market research report provides detailed data analysis of the beer and cider sector...
-
Product Insights
Gsd Land M – Tasek Gelugor Commercial Complex – Penang
Equip yourself with the essential tools needed to make informed and profitable decisions with our Gsd Land M - Tasek Gelugor Commercial Complex - Penang report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
Respiratory Disease Tests – Gold Standard Diagnostics – GSD
GlobalData, the industry analysis specialist, has released its latest report: Respiratory Disease Tests - Gold Standard Diagnostics - GSD. The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. In addition, the final selling pricing of medical devices is also impacted by...
-
Product Insights
COVID-19 Tests – Gold Standard Diagnostics – GSD
GlobalData, the industry analysis specialist, has released its latest report: COVID-19 Tests - Gold Standard Diagnostics - GSD. The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. In addition, the final selling pricing of medical devices is also impacted by the...
-
Company Profile
The Depository Trust & Clearing Corp – Company Profile
The Depository Trust & Clearing Corporation Corp (DTCC) is a provider of clearing services, settlement and asset services, wealth management services, and derivatives services. Under the Clearing services the company offers equities clearing, fixed income clearing-NSCC-CMU, fixed income clearing-FICC-GSD, fixed income clearing-FICC-MSBD, and equities clearing trade capture. Through the settlement, and asset services DTCC provides settlement, securities processing, issuer services, underwriting, global tax services, corporate action processing, and agent servicing. Wealth management services comprise of mutual funds, insurance and retirement,...
Add to Basket -
Product Insights
Eastern Equine Encephalitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Eastern Equine Encephalitis Pipeline Drugs Market Report Overview The Eastern Equine Encephalitis pipeline drugs market research report provides comprehensive information on the Eastern Equine Encephalitis targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also reviews key players involved in Eastern Equine Encephalitis targeted therapeutics development with respective active and dormant or discontinued projects.
-
Product Insights
COVID 19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
COVID 19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) are used to amplify and detect the specific nucleic acid sequences of SARS-CoV-2 virus at the point-of-care. The COVID 19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) pipeline market research report provides comprehensive information about the COVID 19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Moreover, the report...